BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 99 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,533,000 | +61.3% | 3,401,744 | +12.4% | 0.00% | +33.3% |
| Q3 2016 | $13,352,000 | +64.9% | 3,027,595 | +6.2% | 0.00% | +50.0% |
| Q2 2016 | $8,095,000 | +2.1% | 2,850,238 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $7,926,000 | -72.5% | 2,800,786 | +0.4% | 0.00% | -71.4% |
| Q4 2015 | $28,789,000 | -13.3% | 2,789,584 | -4.2% | 0.01% | -22.2% |
| Q3 2015 | $33,194,000 | -21.3% | 2,911,728 | +3.1% | 0.01% | -10.0% |
| Q2 2015 | $42,158,000 | +63.2% | 2,823,718 | -1.3% | 0.01% | +66.7% |
| Q1 2015 | $25,834,000 | -24.2% | 2,860,900 | +2.0% | 0.01% | -25.0% |
| Q4 2014 | $34,103,000 | +36.8% | 2,804,541 | +10.1% | 0.01% | +14.3% |
| Q3 2014 | $24,921,000 | -23.6% | 2,548,170 | -0.4% | 0.01% | -22.2% |
| Q2 2014 | $32,616,000 | +243.3% | 2,558,112 | +184.8% | 0.01% | +200.0% |
| Q1 2014 | $9,502,000 | +49.8% | 898,132 | +7.6% | 0.00% | +50.0% |
| Q4 2013 | $6,344,000 | +487.4% | 834,789 | +462.8% | 0.00% | – |
| Q3 2013 | $1,080,000 | +462.5% | 148,335 | +19.6% | 0.00% | – |
| Q2 2013 | $192,000 | – | 123,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |